Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Serum mianserin and ageing

E Leinonen¹, H Koponen, U Lepola

¹Psychiatric Research Clinic of Kuopio, Finland.

Progress in Neuro-Psychopharmacology & Biological Psychiatry

|September 1, 1994

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Blended learning and an exploration of student expectations on a Master's prosthodontics programme with reassessment at five years.

British dental journal·2018

Same author

Sixfold Post-Fracture Mortality in 16- To 30-Year-Old Patients-Suicides, Homicides, and Intoxications Among Leading Causes of Death.

Scandinavian journal of surgery : SJS : official organ for the Finnish Surgical Society and the Scandinavian Surgical Society·2018

Same author

Lifetime use of psychiatric medications and cognition at 43years of age in schizophrenia in the Northern Finland Birth Cohort 1966.

European psychiatry : the journal of the Association of European Psychiatrists·2017

Same author

Changes in interleukin-6 levels during electroconvulsive therapy may reflect the therapeutic response in major depression.

Acta psychiatrica Scandinavica·2016

Same author

Association study of arcuate nucleus neuropeptide Y neuron receptor gene variation and serum NPY levels in clozapine treated patients with schizophrenia.

European psychiatry : the journal of the Association of European Psychiatrists·2016

Same author

The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment response.

Translational psychiatry·2016

Mianserin, an antidepressant, shows comparable efficacy to tricyclic antidepressants with fewer side effects in the elderly. Age does not significantly alter mianserin pharmacokinetics, making it a safe option for older patients.

Area of Science:

Pharmacology
Geriatrics
Psychiatry

Background:

Mianserin is a tetracyclic antidepressant known for its low anticholinergic and cardiovascular side effects.
Its efficacy is comparable to tricyclic antidepressants, and it is frequently prescribed in Europe, particularly for elderly outpatients.

Purpose of the Study:

To evaluate the efficacy of mianserin in depressive psychiatric inpatients.
To investigate the impact of aging and concurrent psychotropic medications on serum mianserin concentrations.

Main Methods:

Serum mianserin concentrations were analyzed in 169 depressive psychiatric inpatients.
Patients were stratified by age groups (young, middle-aged, old) and compared.
The influence of concomitant neuroleptic use on serum mianserin levels was assessed.

Related Experiment Videos

Main Results:

Serum mianserin concentrations and interindividual variations did not significantly differ across age groups.
Elderly men and women showed similar dose-related drug concentrations.
Concomitant neuroleptic use increased serum mianserin concentrations in the elderly.
Patients with good clinical improvement exhibited higher mean serum mianserin concentrations.

Conclusions:

Advancing age does not appear to cause clinically significant changes in mianserin pharmacokinetics.
The therapeutic profile of mianserin is not altered by aging.
Mianserin is a suitable antidepressant with a favorable side-effect profile for the elderly population.